Features | Partner Sites | Information | LinkXpress
Sign In
PZ HTL SA
GLOBETECH PUBLISHING LLC
GLOBETECH PUBLISHING LLC

Avian Influenza Virus Genome Contains Mutations Favorable for Growth in Humans

By BiotechDaily International staff writers
Posted on 02 May 2013
A collaborative study conducted by researchers in the United States and Japan analyzed isolates of the A(H7N9) avian influenza virus taken from Chinese patients and from samples derived from birds and the environment in the area of Shanghai.

As of April 20, 2013, there had been a total of 96 laboratory-confirmed cases of human infection with the avian influenza A(H7N9) virus in China, and 18 of the patients had died.

Investigators from the University of Wisconsin (Madison, USA) and the University of Tokyo (Japan) analyzed the genetic sequences of H7N9 isolates from four human flu patients as well as samples derived from birds and the environs of a Shanghai market.

They reported in the April 12, 2013, online edition of the journal Eurosurveillance that while the hemagglutinin (HA) and neuraminidase genes probably originated from Eurasian avian influenza viruses, the remaining genes were closely related to avian H9N2 influenza viruses. Several characteristic amino acid changes in HA and the PB2 RNA polymerase subunit probably facilitated binding to human-type receptors and efficient replication in mammals, respectively, highlighting the pandemic potential of the novel A(H7N9) viruses.

"The human isolates, but not the avian and environmental ones, have a protein mutation that allows for efficient growth in human cells and that also allows them to grow at a temperature that corresponds to the upper respiratory tract of humans, which is lower than you find in birds," said contributing author Dr. Yoshihiro Kawaoka, professor of virology at the University of Wisconsin. "These viruses possess several characteristic features of mammalian influenza viruses, which likely contribute to their ability to infect humans and raise concerns regarding their pandemic potential. Although it is too early to predict its potential to cause a pandemic, signs that the virus is adapting to mammalian and, in particular, human hosts are unmistakable."

Related Links:

University of Wisconsin
University of Tokyo




comments powered by Disqus

Channels

Drug Discovery

view channel
Image: The nano-cocoon drug delivery system is biocompatible, specifically targets cancer cells, can carry a large drug load, and releases the drugs very quickly once inside the cancer cell. Ligands on the surface of the \"cocoon\" trick cancer cells into consuming it. Enzymes (the “worms\" in this image) inside the cocoon are unleashed once inside the cell, destroying the cocoon and releasing anticancer drugs into the cell (Photo courtesy of Dr. Zhen Gu, North Carolina State University).

Novel Anticancer Drug Delivery System Utilizes DNA-Based Nanocapsules

A novel DNA-based drug delivery system minimizes damage to normal tissues by utilizing the acidic microenvironment inside cancer cells to trigger the directed release of the anticancer drug doxorubicin (DOX).... Read more

Lab Technologies

view channel

Experimental Physicists Find Clues into How Radiotherapy Kills Cancer Cells

A new discovery in experimental physics has implications for a better determination of the process in which radiotherapy destroys cancer cells. Dr. Jason Greenwood from Queen’s University Belfast (Ireland) Center for Plasma Physics collaborated with scientists from Italy and Spain on the work on electrons, and published... Read more

Business

view channel

Interest in Commercial Applications for Proteomics Continues to Grow

Increasing interest in the field of proteomics has led to a series of agreements between private proteomic companies and academic institutions as well as deals between pharmaceutical companies and novel proteomics innovator biotech companies. Proteomics is the study of the structure and function of proteins.... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.